HINGE HEALTH INC-A (HNGE) Stock Earnings Estimates
NYSE:HNGE • US4333131039
42.325 USD
+0.41 (+0.97%)
Last: Feb 20, 2026, 09:55 AM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 292.73M | 390.404M 33.37% | 587.86M 50.58% | 741.23M 26.09% | 874.21M 17.94% | 1.065B 21.82% | 1.191B 11.83% | 1.358B 14.02% | 1.527B 12.44% | |
| EBITDA YoY % growth | -124.887M | -18.479M 85.20% | -541.238M -2,828.94% | 150.3M 127.77% | 194.15M 29.17% | 271.83M 40.01% | 317.22M 16.70% | 365.06M 15.08% | 414.22M 13.47% | |
| EBIT YoY % growth | -130.514M | -24.429M 81.28% | -546.371M -2,136.57% | 136.72M 125.02% | 172.3M 26.02% | 259.18M 50.42% | 302.63M 16.76% | 348.43M 15.13% | 395.56M 13.53% | |
| Operating Margin | -44.59% | -6.26% | -92.94% | 18.45% | 19.71% | 24.34% | 25.41% | 25.66% | 25.90% | |
| EPS YoY % growth | N/A | N/A | N/A | 1.56 5.30% | 1.94 24.81% | 2.61 34.29% | 2.97 13.67% | 3.34 12.37% | 3.69 10.70% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.34 | 0.38 -46.51% | 0.41 -6.92% | 0.48 -2.98% | 0.39 14.61% | 0.44 15.87% | 0.48 16.62% | 0.56 17.68% |
| Revenue Q2Q % growth | 171.89M 38.82% | 174.86M 25.71% | 185.44M 20.25% | 191.28M 12.04% | 189.74M 10.38% | 196.67M 12.47% | 203.16M 9.56% | 211.63M 10.64% |
| EBITDA Q2Q % growth | 33.894M 134.72% | 35.414M 106.13% | 38.615M 1,868.90% | 45.854M 41.57% | 32.964M -2.74% | 38.49M 8.69% | 43.636M 13.00% | 57.171M 24.68% |
| EBIT Q2Q % growth | 28.811M 119.31% | 32.574M 105.61% | 35.936M 689.79% | 40.721M 49.40% | 34.659M 20.30% | 39.14M 20.16% | 42.632M 18.63% | 51.671M 26.89% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 0.49 | 0.40 | 0.09 | 21.95% |
| Q3 2025 Q2Q % growth | 0.44 | 0.23 | 0.21 | 92.15% |
| Q2 2025 Q2Q % growth | 0.71 | 0.09 | 0.62 | 703.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 170.726M -56.27% | 159.77M | 10.956M | 6.86% |
| Q3 2025 Q2Q % growth | 154.211M | 144.98M | 9.231M | 6.37% |
| Q2 2025 Q2Q % growth | 139.098M | 127.86M | 11.238M | 8.79% |
| Q1 2025 Q2Q % growth | 123.825M 49.71% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.55% | 70.42% | 148.65% |
| Revenue | -0.01% | 1.99% | 0% | 4.22% |